Different evolutionary pathways of HIV-1 between fetus and mother perinatal transmission pairs indicate unique immune selection in fetuses

Cell Reports Medicine - Tập 2 - Trang 100315 - 2021
Manukumar Honnayakanahalli Marichannegowda1, Michael Mengual1, Amit Kumar2, Elena E. Giorgi3, Joshua J. Tu2, David R. Martinez2,4, Ethan O. Romero-Severson3, Xiaojun Li1, Liping Feng5, Sallie R. Permar1,2,4,6, Feng Gao1,7
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
2Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA
3Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87544, USA
4Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA
5Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710 USA
6Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
7School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China

Tài liệu tham khảo

UNAIDS Global HIV & AIDS statistics — 2020 fact sheet. https://www.unaids.org/en/resources/fact-sheet. Wolinsky, 1992, Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants, Science, 255, 1134, 10.1126/science.1546316 Mahy, 2010, What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs, Sex. Transm. Infect., 86, ii48, 10.1136/sti.2010.045989 Dorenbaum, 2002, Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial, JAMA, 288, 189, 10.1001/jama.288.2.189 Bailey, 2018, HIV treatment in pregnancy, Lancet HIV, 5, e457, 10.1016/S2352-3018(18)30059-6 Kellerman, 2010, HIV testing for children in resource-limited settings: what are we waiting for?, PLoS Med., 7, e1000285, 10.1371/journal.pmed.1000285 Tang, 2010, HIV and pregnancy in resource-poor settings, Rev. Obstet. Gynecol., 3, 66 Permar, 2015, Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission, J. Clin. Invest., 125, 2702, 10.1172/JCI81593 Fouda, 2018, The impact of IgG transplacental transfer on early life immunity, Immunohorizons, 2, 14, 10.4049/immunohorizons.1700057 Martinez, 2017, Maternal binding and neutralizing IgG responses targeting the C-terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk, J. Virol., 91, e02422-16, 10.1128/JVI.02422-16 Albrecht, 2020, Vertically transferred immunity in neonates: mothers, mechanisms and mediators, Front. Immunol., 11, 555, 10.3389/fimmu.2020.00555 Martinez, 2019, Fc characteristics mediate selective placental transfer of IgG in HIV-infected women, Cell, 178, 190, 10.1016/j.cell.2019.05.046 Wilcox, 2017, Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy, Front. Immunol., 8, 1294, 10.3389/fimmu.2017.01294 Palmeira, 2012, IgG placental transfer in healthy and pathological pregnancies, Clin. Dev. Immunol., 2012, 985646, 10.1155/2012/985646 Martinez, 2020, Maternal broadly neutralizing antibodies can select for neutralization-resistant, infant-transmitted/founder HIV variants, MBio, 11, e00176-20, 10.1128/mBio.00176-20 Moody, 2015, Strain-specific V3 and CD4 binding site autologous HIV-1 neutralizing antibodies select neutralization-resistant viruses, Cell Host Microbe, 18, 354, 10.1016/j.chom.2015.08.006 Kumar, 2018, Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma, PLoS Pathog., 14, e1006944, 10.1371/journal.ppat.1006944 Wilcox, 2018, Beyond passive immunity: is there priming of the fetal immune system following vaccination in pregnancy and what are the potential clinical implications?, Front. Immunol., 9, 1548, 10.3389/fimmu.2018.01548 Frascoli, 2018, Alloreactive fetal T cells promote uterine contractility in preterm labor via IFN-γ and TNF-α, Sci. Transl. Med., 10, eaan2263, 10.1126/scitranslmed.aan2263 Agrawal, 2012, Intrauterine infection and preterm labor, Semin. Fetal Neonatal Med., 17, 12, 10.1016/j.siny.2011.09.001 Neta, 2010, Umbilical cord serum cytokine levels and risks of small-for-gestational-age and preterm birth, Am. J. Epidemiol., 171, 859, 10.1093/aje/kwq028 McGovern, 2017, Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2, Nature, 546, 662, 10.1038/nature22795 Dauby, 2020, Fetal infections: immune response to infections during fetal life, 215 Bunders, 2014, Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1, Sci. Rep., 4, 6690, 10.1038/srep06690 Giorgi, 2010, Estimating time since infection in early homogeneous HIV-1 samples using a poisson model, BMC Bioinformatics, 11, 532, 10.1186/1471-2105-11-532 Suchard, 2018, Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10, Virus Evol., 4, vey016, 10.1093/ve/vey016 Song, 2018, Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection, Nat. Commun., 9, 1928, 10.1038/s41467-018-04217-5 Giorgi, 2020, Estimating the timing of early simian-human immunodeficiency virus infections: a comparison between Poisson Fitter and BEAST, MBio, 11, e00324-20, 10.1128/mBio.00324-20 Murrell, 2012, Detecting individual sites subject to episodic diversifying selection, PLoS Genet., 8, e1002764, 10.1371/journal.pgen.1002764 Zhou, 2007, Structural definition of a conserved neutralization epitope on HIV-1 gp120, Nature, 445, 732, 10.1038/nature05580 Moore, 2012, Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape, Nat. Med., 18, 1688, 10.1038/nm.2985 Pejchal, 2010, Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1, Proc. Natl. Acad. Sci. USA, 107, 11483, 10.1073/pnas.1004600107 Kwong, 2018, HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure, Immunity, 48, 855, 10.1016/j.immuni.2018.04.029 Sok, 2018, Recent progress in broadly neutralizing antibodies to HIV, Nat. Immunol., 19, 1179, 10.1038/s41590-018-0235-7 Schatten, 2007 Codaccioni, 2019, Placental transfer of xenobiotics in pregnancy physiologically-based pharmacokinetic models: structure and data, Comput. Toxicol., 12, 100111, 10.1016/j.comtox.2019.100111 Chatuphonprasert, 2018, Physiology and pathophysiology of steroid biosynthesis, transport and metabolism in the human placenta, Front. Pharmacol., 9, 1027, 10.3389/fphar.2018.01027 Underwood, 2005, Amniotic fluid: not just fetal urine anymore, J. Perinatol., 25, 341, 10.1038/sj.jp.7211290 Mold, 2008, Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero, Science, 322, 1562, 10.1126/science.1164511 Claas, 1988, Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life, Science, 241, 1815, 10.1126/science.3051377 Aagaard, 2014, The placenta harbors a unique microbiome, Sci. Transl. Med., 6, 237ra65 Campbell, 2015, Mechanisms of allergic disease - environmental and genetic determinants for the development of allergy, Clin. Exp. Allergy, 45, 844, 10.1111/cea.12531 Berry, 1992, Circulating lymphocyte subsets in second- and third-trimester fetuses: comparison with newborns and adults, Am. J. Obstet. Gynecol., 167, 895, 10.1016/S0002-9378(12)80008-1 Rechavi, 2015, Timely and spatially regulated maturation of B and T cell repertoire during human fetal development, Sci. Transl. Med., 7, 276ra25, 10.1126/scitranslmed.aaa0072 Douglas, 2017, The role of maternal HIV envelope-specific antibodies and mother-to-child transmission risk, Front. Immunol., 8, 1091, 10.3389/fimmu.2017.01091 Thobakgale, 2007, Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants, J. Virol., 81, 12775, 10.1128/JVI.00624-07 Moody, 2016, Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies, Sci. Immunol., 1, aag0851, 10.1126/sciimmunol.aag0851 Keele, 2008, Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection, Proc. Natl. Acad. Sci. USA, 105, 7552, 10.1073/pnas.0802203105 2009 Anderson, 1997, The placental barrier to maternal HIV infection, Obstet. Gynecol. Clin. North Am., 24, 797, 10.1016/S0889-8545(05)70345-4 Gouy, 2010, SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building, Mol. Biol. Evol., 27, 221, 10.1093/molbev/msp259 Nei, 1986, Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions, Mol. Biol. Evol., 3, 418 Montefiori, 2009, Measuring HIV neutralization in a luciferase reporter gene assay, Methods Mol. Biol., 485, 395, 10.1007/978-1-59745-170-3_26